Ix Biopharma Ltd News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Ix biopharma ltd. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Ix Biopharma Ltd Today - Breaking & Trending Today

iX Biopharma Targets Diabetes with New Wafer

IX Biopharma Ltd. (SG:42C) has released an update. iX Biopharma Ltd is developing a new sublingual semaglutide wafer, iXB 401, aimed at treating di. ....

Ix Biopharma Ltd , Reaking News ,

MeltMed® Rings in the Holidays with Reduced Pricing and New NAD+ Starter Packs

Begin your Wellness Journey with Regenerate Starter Packs;Scientifically formulated to maximise effectiveness of NAD supplement;Enjoy savings of 50%NEW YORK, Dec. 4, 2023 /PRNewswire/ MeltMed®, an innovative ....

Megan Jewett , Ix Biopharma Ltd , Therapeutic Goods Administration , Business Development , Singapore Exchange Securities Trading , Wellness Journey , Regenerate Starter Packs , Radiance Glutathione , Starter Packs , Regenerate Starter Pack , Business Development Manager , Current Good Manufacturing Practice ,

iX Biopharma Signs Exclusive License Agreement For Wafermine And Other Sublingual Ketamine Wafer Products

Press release content from PR Newswire. The AP news staff was not involved in its creation. ....

United States , New York , Hong Kong , Raj Mehra , Geddy Lee , X Biopharma Waferi , European Medicines Agency , Seelos Therapeutics Inc , Drug Administration , Singapore Exchange Securities Trading Limited , Ix Biopharma Ltd , Seelos Therapeutics Inc Nasdaq , Seelos Therapeutics , Scientific Advice , Complex Regional Pain Syndrome , Licensed Products , Pr Newswire , Ix Biopharma Ltd ,

Seelos Therapeutics Announces Acquisition of an Exclusive License of iX Biopharma's Proprietary Wafer-Based Delivery Platform for Sublingual Ketamine

Press release content from PR Newswire. The AP news staff was not involved in its creation. ....

Hong Kong , New York , United States , Raj Mehra , Geddy Lee , Anthony Marciano , Ix Biopharma , Prnewswire Seelos Therapeutics Inc , Seelos Therapeutics Inc , Drug Administration , Exchange Commission , Singapore Exchange Securities Trading Limited , Ix Biopharma Ltd , License Agreement , Complex Regional Pain Syndrome , Orphan Drug , Seelos Therapeutics , Private Securities Litigation Reform Act , Licensed Products , Annual Report , Quarterly Reports , Pr Newswire , Ix Biopharma Ltd ,

Seelos Therapeutics Announces Acquisition of an Exclusive License of iX Biopharma's Proprietary Wafer-Based Delivery Platform for Sublingual Ketamine

/PRNewswire/ Seelos Therapeutics, Inc. (Nasdaq: SEEL), a clinical-stage biopharmaceutical company focused on the development of therapies for central. ....

Hong Kong , New York , United States , Raj Mehra , Geddy Lee , Anthony Marciano , Exchange Commission , Ix Biopharma , Seelos Therapeutics Inc , Drug Administration , Singapore Exchange Securities Trading Limited , Ix Biopharma Ltd , Seelos Therapeutics , License Agreement , Complex Regional Pain Syndrome , Orphan Drug , Private Securities Litigation Reform Act , Licensed Products , Annual Report , Quarterly Reports , Communications Officer ,